Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs.
Antineoplastic Agents
/ chemical synthesis
Antiviral Agents
/ chemical synthesis
Cell Line, Tumor
Cell Proliferation
/ drug effects
Drug Design
Drug Screening Assays, Antitumor
ErbB Receptors
/ antagonists & inhibitors
HL-60 Cells
Herpesvirus 3, Human
/ drug effects
Humans
MCF-7 Cells
Microbial Sensitivity Tests
Molecular Docking Simulation
Molecular Structure
Nucleosides
/ chemical synthesis
Oxadiazoles
/ chemical synthesis
Protein Kinase Inhibitors
/ chemical synthesis
Receptor, ErbB-2
/ antagonists & inhibitors
1,3,4-Oxadiazole
anticancer activity
antiviral activity
homonucleosides
molecular docking
Journal
Nucleosides, nucleotides & nucleic acids
ISSN: 1532-2335
Titre abrégé: Nucleosides Nucleotides Nucleic Acids
Pays: United States
ID NLM: 100892832
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
14
5
2020
medline:
12
1
2021
entrez:
14
5
2020
Statut:
ppublish
Résumé
Herein, we report the synthetic strategies and characterization of some novel 1,3,4-oxadiazole homonucleoside analogs that are relevant to potential antitumor and cytotoxic activities. The structure of all compounds is confirmed using various spectroscopic methods such as
Identifiants
pubmed: 32397827
doi: 10.1080/15257770.2020.1761982
doi:
Substances chimiques
Antineoplastic Agents
0
Antiviral Agents
0
Nucleosides
0
Oxadiazoles
0
Protein Kinase Inhibitors
0
1,3,4-oxadiazole
20O2F20OUR
EGFR protein, human
EC 2.7.10.1
ERBB2 protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM